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This report summarises a workshop convened by the UK Food Standards Agency 
(FSA) on 14 October 2008 to discuss current FSA funded research on carbohydrate 
and cardiovascular health. The objective of this workshop was to discuss the results 
of recent research and to identify any areas which could inform future FSA research 
calls. This workshop highlighted that the FSA is currently funding some of the largest, 
well-powered intervention trials investigating the type of fat and carbohydrate, whole 
grains and fruit and vegetables, on various CVD risk factors. Results of these trials 
will make a substantive contribution to the evidence on diet and cardiovascular risk. 
 
 
The UK Food Standards Agency (FSA) convened a workshop on 14 October 2008 
chaired by Professor Philip Calder to discuss current FSA funded research on 
carbohydrate and cardiovascular health commissioned under its N02 Diet and 
Cardiovascular Disease research programme. In particular the workshop focused on 
research from ongoing and recently completed dietary intervention studies 
investigating the impact of the type of carbohydrate and fat, whole grains, and fruit 
and vegetables, on cardiovascular disease (CVD) risk. The aim of the workshop was 
to discuss the results and implications of this research and to identify any areas which 
could inform future FSA research calls.  
 
Dr John Stanley, N02 Programme Advisor, presented an overview of the evidence 
surrounding the three areas: type of carbohydrate and fat; wholegrain; and fruit and 
vegetables, on CVD risk. This overview was followed by project specific 
presentations by Dr Susan Jebb, Dr Frank Thies, Professor Chris Seal, Dr Damian 
McCall and Professor Tom Sanders. The presentations were followed by a general 
discussion of the scientific issues raised during the presentations.  
 
 
 
 
 
 
Background 
 
Cardiovascular health  
 
Cardiovascular disease is the leading cause of death world-wide and the World Health 
Organisation (WHO) suggests one-third of all global deaths (15.3 million) are caused 
by CVD1. In the UK CVD is one of the main causes of premature death, attributing to 
30% and 22% of premature deaths in men and women respectively2. In 2006, CVD 
accounted for 197,767 deaths or 35% of all deaths, of which 94,381 were from 
coronary heart disease (CHD) and 55,098 deaths from stroke2. About 851,000 people 
in the UK have had a heart attack and over 1.1million suffer from angina. In addition, 
about 707,000 people have definite heart failure2. 
 
The burden of CVD is a major public health concern, and there is convincing 
evidence that dietary and nutritional factors can reduce risk1. In working towards its 
key strategic aim to reduce diet-related disease, the FSA commissions research into 
diet, nutrition and CVD risk under its N02 Diet and Cardiovascular Disease research 
programme.  
 
The aim of this programme is to provide sound scientific evidence on the biological 
effects of dietary components on cardiovascular health which can be used in the 
formulation of healthy eating recommendations for consumers. The scientific and 
technical objectives of the programme focus on long term intervention studies in free 
living humans examining the effects of modifying diet (e.g. increasing fruit and 
vegetable intake) on cardiovascular health, with the maintenance of cardiovascular 
health and the prevention of CVD as the main focus. 
 
Measurement of cardiovascular disease 
 
The measurement of CVD itself is not a practical endpoint for most intervention trials. 
In current FSA trials, CVD risk factors tend to be used as endpoints. In addition to 
traditional, well-established risk factors such as dyslipideaemia, insulin resistance and 
hypertension, an earlier FSA workshop3 recommended that measures of endothelial 
function may provide a useful non-invasive methodology for assessing a clinically 
relevant surrogate endpoint. Taking this recommendation into account the FSA is 
moving towards commissioning further research using novel measures of vascular 
function and continuing its work on insulin resistance where the impact of dietary 
modification is less well characterised than for dyslipideaemia or hypertension. 
 
Dietary fat, carbohydrate and cardiovascular disease  
 
Current dietary recommendations advise the consumption of no more than 10% of 
dietary energy from saturated fat4; however current intakes in the UK population 
average 13%5. There is evidence to suggest that a diet high in saturated fat (SFA) 
increases the blood concentration of total cholesterol particularly low density 
lipoprotein (LDL) cholesterol in the bloodstream, which is strongly associated with 
risk of CVD6. On the other hand, replacing fat with carbohydrate decreases HDL 
cholesterol, which is associated with increased risk of CVD7.  However, cross-
sectional studies have suggested that the HDL lowering effect of carbohydrate may be 
influenced by the glycemic index of the diet8,9. The Prospective Triallist 
Collaboration6 concluded that the ratio of total:HDL cholesterol was twice as 
informative of CVD risk than total cholesterol. A central issue in public health 
nutrition is to determine the optimal quantity and composition of both fat and 
carbohydrate in the diet to reduce the risk of CVD. 
 
A review by McAuley and Mann10 assessed several intervention trials comparing the 
effects of saturated and unsaturated fat on insulin sensitivity in healthy individuals 
and type 2 diabetics. Results from these trials were inconclusive, with many being 
underpowered and of a short duration.  
 
To date the largest published trial investigating the effect of type of dietary fat on 
insulin sensitivity is the KANWU study11.  One hundred and sixty two subjects were 
randomised to either a high SFA or high monounsaturated fat (MUFA) diet. Insulin 
sensitivity measured by intravenous glucose tolerance test (IVGTT) was significantly 
lowered by the high SFA diet but not by the MUFA diet. A post-hoc analysis 
suggested that this effect of MUFA only occurred in the subjects that consumed a 
total fat below <37% of energy. 
 
In another randomised cross-over trial12 59 subjects followed a SFA rich diet for 28 
days and were then randomised to a low fat, high carbohydrate diet or a high MUFA 
diet (‘Mediterranean diet’) for 28 days in each group. Both diets demonstrated an 
improvement in insulin sensitivity compared to a diet higher in saturated fat. 
A number of trials have also investigated percentage and type of fat and carbohydrate 
on measurements of vascular function. Perez-Jimenez et al.13 reported a high MUFA 
diet decreased plasma von Willebrand Factor (vWF), tissue factor pathway inhibitor 
(TFPI) and plasminogen activator inhibitor -1(PAI-1) in 25 healthy male subjects. 
Similarly Fuentes et al.14 observed an improvement in vascular function measured by 
flow mediated dilation (FMD) in 22 hypercholesterolaemic men consuming a high 
MUFA diet. Keogh et al.15 also reported that a high SFA diet resulted in significant 
deterioration in FMD of the brachial artery compared to the high PUFA, MUFA or 
carbohydrate diets. In comparison, Ashton et al.16 observed no effect of a modified fat 
(with a high MUFA content) or a low fat, high carbohydrate diet on arterial elasticity 
in 28 healthy subjects. No effect on FMD of the brachial artery was observed in a 
randomised cross over trial of 32 healthy subjects consuming a low fat diet17. 
The majority of studies have been short in duration, conducted in a small number of 
subjects, and have been statistically underpowered. In 2003, the FSA commissioned a 
large multi-centre trial to investigate the impact of the amount and type of dietary fat 
and carbohydrate (CHO) on metabolic syndrome. 
 
N02031 – Impact of the amount and type of dietary fat and carbohydrate on 
metabolic syndrome (RISCK study) 
 
Dr Susan Jebb presented on the large FSA funded multi-centre randomised controlled 
parallel study investigating the impact of the amount and type of dietary fat and CHO 
on metabolic syndrome.  
 
The main aim of the RISCK (University of Reading, Imperial College, University of 
Surrey, MRC Human Nutrition Research, Cambridge and Kings College London) 
study was to identify and recruit subjects predisposed to the development of the 
metabolic syndrome; to develop a strategy to attain five isoenergetic dietary groups 
differing only in the amount and composition of dietary fat and carbohydrate; and to 
test the impact of these changes in dietary composition on CVD risk factors 
associated with metabolic syndrome, especially insulin sensitivity.  
 
Using a combination of existing guidelines for identification of the metabolic 
syndrome and clinical cut-offs associated with increased risk of CVD, a screening 
tool was developed to identify and recruit subjects at risk of the metabolic syndrome.  
 
The five isoenergetic dietary intervention groups developed for this study were:  
• the reference diet – high SFA/high glycemic index  (38% energy from fat, 
18% energy from SFA, 12% energy from MUFA, 6% energy from PUFA and 
45% energy from CHO); 
•  high MUFA, high GI diet (38% energy from fat, 10% energy from SFA, 20% 
energy from MUFA, 6% from PUFA and 45% from CHO);  
• high MUFA, low GI diet (38% energy from fat, 10% energy from SFA, 20% 
energy from MUFA, 6% from PUFA and 45% from CHO);  
• low fat, high GI diet (28% energy from fat, 10% energy from SFA, 12% 
energy from MUFA, 6% energy from PUFA and 55% energy from CHO).  
• low fat, low GI diet (28% energy from fat, 10% energy from SFA, 12% 
energy from MUFA, 6% energy from PUFA and 55% energy from CHO).  
 
To achieve the fat and CHO modification, sources of fat and CHO were replaced with 
study foods specifically developed with relevant fatty acid profile and CHO content18. 
 
Subjects completed a 4 week run in phase where the reference diet was consumed 
prior to being randomised to one of the five dietary groups for a further 24 weeks. In 
total 720 subjects were recruited with 548 successfully completing the trial. Almost a 
quarter of subjects did not complete the study, primarily due to the demands 
associated with making extensive changes to their dietary patterns. Most dropouts 
occurred during the run-in phase prior to the main intervention period. 
  
The study was powered to measure the primary outcome measure insulin resistance, 
which was measured by reduced sampling IVGTT protocol, secondary outcome 
measures included many CVD risk markers, including blood lipid profiles, blood 
pressure, inflammatory markers and markers of endothelial function. Compliance was 
measured through diet diaries and analysis of plasma fatty acids. Further details of the 
study design have been previously published19. 
 
The screening tool successfully identified participants predisposed to CVD. The 
dietary targets for each diet were generally met and changes in plasma phospholipid 
fatty acids confirmed compliance. Overall no significant impact of high MUFA, low 
fat or GI on fasting or post-prandial measures of insulin sensitivity was observed. The 
replacement of SFA with either MUFA or CHO resulted in LDL lowering effects. 
There were additional reductions in total and LDL cholesterol on the low GI diets 
while the high MUFA diet led to a more favourable total cholesterol:HDL ratio.  
 
This is currently one of the largest controlled dietary intervention trials and is 
sufficiently powered to detect effects of replacing SFA with MUFA and CHO and the 
effect on metabolic syndrome and CVD risk factors. 
 
Whole grain consumption and cardiovascular disease 
 
There is good epidemiological evidence demonstrating a protective effect of high 
consumption of whole grains against CVD risk20,21,22. A meta-analysis of 12 cohort 
studies23 concluded that subjects with the highest intake of whole grain had around 
26% lower risk of developing CHD compared to those with the lowest intake. An 
update on this meta-analysis, which included 13 studies, reported a 29% reduction in 
CHD risk. In a recent meta-analysis of 7 prospective cohort studies24 a 21% reduction 
in CHD risk was reported in the high consumers of whole grain compared with the 
low consumers. 
 
To date the majority of the evidence is based on observational studies and although it 
is compelling, there is a lack of data from large well designed intervention trials 
sufficiently powered to detect a causal link. One meta-analysis25 analysed 10 
randomised controlled trials on wholegrain foods and effects on CHD mortality, 
morbidity and on risk factors for CHD. Results from this meta-analysis showed 
significant lowering effects on total and LDL cholesterol concentrations, however 
most of the trials were short term, of poor quality and insufficiently powered. In 
addition 8 out of the 10 studies focused on oats as the wholegrain source.  
 
There is therefore a need for large, well designed intervention trials with sufficient 
power to detect an effect of whole grain on CVD risk factors. In 2004, the FSA 
commissioned two such trials investigating the effect of whole grain on CVD risk 
factors. 
 
N02035 – Comparison of effects of increased whole grain foods on markers of 
cardiovascular risk 
 
Dr Frank Thies presented on the FSA funded study designed to investigate the effects 
of increased intake of wholegrain foods on markers of CVD risk. The aims of this 
study were: to test the hypothesis that three servings of wholegrain foods per day have 
a cardio-protective role; to characterise the effects of this intervention on 
cardiovascular risk factors; and to compare the effects of wheat-based wholegrain 
foods with a mixture of wheat and oat-based wholegrain foods. 
 
Two hundred and thirty three healthy subjects aged 40-65 years with a BMI between 
25 and 35 kg/m2 were randomised into one of three intervention groups, control 
(refined cereal diet, avoidance of wholegrain foods); whole wheat diet (3 servings of 
wholegrain foods) or whole wheat and oat diet (3 servings of wholegrain foods, 
including oats).  Prior to commencing the 12 week intervention period, subjects took 
part in a 4 week run in phase, where they all consumed a refined cereal diet. The 
subjects randomised to the wheat based whole grain or the whole wheat and oat diet 
replaced three servings of refined cereals with either 3 portions of wheat or wheat and 
oat whole grains.  
 
The primary outcome measure of this study was total and LDL cholesterol (the study 
was powered on these two markers). Blood pressure, lipoprotein profile, 
inflammatory markers and arterial stiffness was also measured at each time point. 
 
In total 206 subjects completed the study. Macronutrient intake did not change 
throughout the trial, except NSP, which increased in the whole grain intervention 
groups. Systolic blood pressure and pulse pressure significantly decreased in the 
whole grain food groups compared to the control group. Systemic markers and lipid 
concentrations did not differ significantly after the intervention. Systemic markers 
remained mostly unaffected by the interventions apart from total and LDL cholesterol 
concentrations which decreased slightly in the refined group. 
 
N02036 – Randomised controlled trial to test the impact of increased consumption 
of wholegrain foods on cardiovascular disease risk (the WHOLEheart study) 
 
Professor Chris Seal presented on the FSA funded study investigating the impact of 
increased consumption of wholegrain foods on CVD risk factors. 
 
This was a multi-centre randomised controlled study, conducted in Newcastle and 
Cambridge. Two hundred and sixty six subjects (aged 18-65 years; BMI > 25 kg/m2) 
who habitually consumed < 1.5 portions of whole grain/day were recruited across the 
two centres. Subjects were randomised to one of three groups: control group (no 
dietary intervention); 3 servings of whole grain/day for 16 weeks; or 3 servings of 
whole grain/day for 8 weeks followed by 6 servings of whole grain/day for 8 weeks. 
Wholegrain foods (e.g. brown rice, breakfast cereal, wholemeal bread etc) were 
provided preweighed and packaged, with labels indicating whole grain portions in 
each packet to aid compliance. 
 
Whole grain-intake was assessed by food frequency questionnaire. Plasma was 
analysed for lipid profile (total, LDL and HDL cholesterol and triglycerides), insulin 
and glucose and further biochemical markers of inflammation and endothelial 
function. Differences between study groups were compared using a random intercepts 
model with time and whole grain-intake as factors. Whole grain-intake was <20g/day 
at baseline, and this increased as expected during the intervention for those receiving 
wholegrain foods.  Whole grain-intake for the control group stayed at about 20g/day 
throughout the study and during the 12 month follow-up period. For the 3 servings 
group, whole grain-intake was about 70 g/day for weeks 8 and 16, and for the second 
intervention group whole grain-intake was 76 g/day at week 8 and 115 g/day at week 
16.  Despite these significant increases in whole grain-intake there were no significant 
changes in plasma LDL cholesterol concentrations or any of the other biomarkers of 
CVD risk tested26.  The pattern of food intake was changed with inclusion of 
wholegrain foods, with several beneficial changes in nutrient intakes, especially 
dietary fibre and many micronutrients27,28.  These data do not support the 
observational data for the health benefits of wholegrain foods, however, the 
intervention may be too short to change the lifelong disease trajectory associated with 
CVD in these overweight volunteers.   
 
In addition to investigating CVD risk the WHOLEheart study was also designed to 
explore factors affecting acceptability, barriers and sustainability of incorporating 
whole grains into the diet by conducting focus groups at 1, 6 and 12 months post 
intervention. These qualitative data provide a valuable insight into consumer 
acceptance of wholegrain foods and the factors which influence food choice at the 
individual and household level. 
 
The results from these two well designed intervention trials provide compelling 
evidence on whether whole grains have a protective effect on cardiovascular health 
 
Fruit and vegetable and cardiovascular disease 
 
A number of cross-sectional and prospective cohort studies have reported a significant 
protective effect of fruit and vegetables on CHD risk and stroke. A meta-analysis of 9 
cohort studies29 reported a beneficial association between fruit and vegetable 
consumption and CHD risk. A more recent meta-analysis of 13 cohort studies30 
demonstrated a 17% decrease in CHD risk from increasing fruit and vegetable 
consumption from less than 3 portions to more than 5 portions per day. A small, 
slightly significant decrease in CHD risk was also noted where intake was increased 
to 3-5 portions per day. A pooled analysis of 9 cohort studies showed increased fruit 
and vegetable intake was associated with a reduced risk of stroke31. Individuals who 
consumed more than 5 servings/day had a significantly reduced risk of stoke 
compared to individuals who had less than 3 servings/day. Elevated blood pressure is 
the major risk factor for stroke and also an important risk factor for CHD32 and it is 
highly plausible that the intake of fruit and vegetables may help prevent the increase 
in blood pressure that occurs with age. 
 
Only a few intervention trials have examined the cardioprotective effect of fruit and 
vegetables. The Dietary Approach to Stop Hypertension (DASH) study of 459 
subjects33 was an 8 week controlled feeding study that assessed the effects on blood 
pressure of increased fruit and vegetable consumption alone or in addition to a 
combination diet (rich in fruit and vegetables, low fat dairy produce and reduced 
amounts of saturated fat, total fat and cholesterol). The decreases in systolic/diastolic 
ambulatory blood pressure were 3.1/2.0 mm on the fruit and vegetable diet, 4.6/2.6 
mm Hg on the combination diet compared changes of -0.2/+0.1 mmg Hg on the 
control diet34.  The blood pressure lowering effects of the diets were greater in those 
with raised blood pressure. 
 
A six month randomised controlled trial used a brief negotiation method to encourage 
increased consumption of fruit and vegetables to at least 5 portions per day35. Subjects 
reported an increase in average fruit and vegetable consumption from 3.4 to 4.9 
portions/day, which resulted in a decrease in systolic blood pressure by 4.0mmHg and 
diastolic blood pressure by 1.5mmHg in the intervention group. Another trial used 
healthy lifestyle prompts36 including a recommendation to increase fruit and 
vegetables and, although fruit and vegetable consumption increased, no significant 
effect on blood pressure was observed. 
 
There is a lack of randomised controlled trials investigating fruit and vegetables and 
CVD risk factors. Large, well designed intervention trials, sufficiently powered with 
vascular function as a primary outcome to detect an effect of fruit and vegetables on 
CVD risk factors are therefore needed. Consequently the FSA has funded two large 
intervention trials investigating the effect of fruit and vegetable consumption on 
vascular function. 
N02029 – The dose dependent effects of fruit and vegetable consumption on 
vascular function 
 
Dr Damian McCall presented on the FSA funded study investigating the dose 
dependent effects of fruit and vegetable consumption on vascular function.  
 
The aim of this randomised dietary intervention trial was to examine the dose-
dependent effects of fruit and vegetable consumption on cardiovascular health in 
subjects with hypertension. One hundred and forty seven volunteers were recruited, 
with 117completing the 4 week run in phase where all subjects were limited to one 
portion of fruit and vegetables a day. Following the run in phase, subjects were 
randomised to 1 of 3 intervention groups, where they consumed either 1, 3 or 6 
portions/day for 8 weeks. Compliance to the dietary intervention was measured by 
contemporaneous 4 day food diaries and assessment of micronutrient status pre- and 
post-intervention. The primary outcome measure of the study was forearm blood flow 
responses to intra-arterial acetylcholine. In addition, central wave reflection, upper 
limb pulse wave velocity and circulating inflammatory markers were measured. 
 
Participants in the 1, 3 and 6 portions/day groups reported consuming on average 1.1, 
3.2 and 5.6 portions of fruit and vegetables respectively, while plasma or serum 
concentrations of ascorbic acid, lutein and β-cryptoxanthin increased across the 
groups in a dose-dependent manner.  For each 1 portion increase in reported fruit and 
vegetable consumption, there was a 6.2% improvement in forearm blood flow 
responses to intra-arterial administration of the endothelium-dependent vasodilator 
acetylcholine (p=0.03). There was no association between increased fruit and 
vegetable consumption and vasodilator responses to sodium nitroprusside, an 
endothelium-independent vasodilator37. 
 
N02030 – A dose response study of the effects of increased fruit and vegetables 
intake on vascular function 
 
Professor Tom Sanders presented on the FSA funded dose response study examining 
the effects of increased fruit and vegetables intake on vascular function. 
 
The aim of this study was to investigate whether increasing the intake of potassium 
rich fruit and vegetables from the UK average of 3 portions a day to the recommended 
level (~5 portions a day providing an additional 20 mmol K) or higher (approximately 
10 portions a day providing 40 mmol K) lowers blood pressure among subjects with 
high normal blood pressure. The effects of an increased intake of potassium when 
provided as a 40 mmol potassium citrate supplement were also explored. 
The primary outcome measure was a change in ambulatory blood pressure and the 
secondary outcome measure was a change in arterial stiffness and endothelial function 
measured as carotid to femoral pulse wave velocity and flow mediated dilatation of 
the brachial artery respectively. 
 
Forty eight subjects with diastolic blood pressure > 80 and < 100mmHg participated 
in the study. Prior to commencing the trial, participants underwent a 3 week run-in 
period on the control level of fruit and vegetable intake. This run-in period was to 
habituate the subjects to the dietary intervention and the ambulatory BP 
measurements and the vascular function measurements. A randomized placebo-
controlled crossover orthogononal design was then used to compare 3 experimental 
versus a control treatment. Each treatment period lasted 6 weeks and was separated 
from the next treatment by a minimum 5 weeks, where subjects were allowed to 
revert to their usual diet. The control treatment involved consuming placebo capsules 
(2 capsules taken 4 times a day) and an intake of fruit and vegetables similar to the 
average UK intake, the experimental treatments compared an additional 20 or 40 
mmol potassium/d provided as fruit and vegetables or 40 mmol/d as potassium citrate 
capsules (2 capsules taken 4 times a day). Personalized dietary advice was provided as 
a unit system (1 unit = 5 mmol potassium) and the participants were provided with 
fruit and vegetables free of cost for the duration of the intervention. Participants were 
blinded to allocation of placebo and potassium citrate capsules, which were matched 
in size and colour. Measurements were carried out at the end of each treatment period 
and researchers undertaking vascular function measurements were blinded to all 
treatment allocations. 
 
Compliance to the dietary intervention was good as measured by self reported fruit 
and vegetable intakes, capsule counts and 24hour urinary potassium collection. 
Overall no changes in ambulatory blood pressure, arterial stiffness, endothelial 
function or serum CRP was observed. 
 
 
Discussion 
 
The workshop highlighted that the FSA is funding some of the largest and most well 
powered intervention trials investigating the type of fat and CHO, whole grains, and 
fruit and vegetable consumption on various cardiovascular health risk factors. These 
trials are of long duration with sufficient subject numbers and power to detect 
clinically important effects. 
 
The majority of the studies presented did not demonstrate strong associations with the 
primary outcome measures. Further investigation into type of whole grain and type of 
fruit and vegetable may explain the differing effects observed between the two whole 
grain studies and two fruit and vegetable studies respectively.  
 
The studies presented as part of the workshop acknowledged the value of a run in 
phase prior to the intervention trial as a way of decreasing the number of drop outs 
during the main intervention. The nature and length of the run in phase will depend on 
the type of intervention. 
 
The present workshop also highlighted that one of the largest nutritional/dietary 
factors for CVD risk is body weight. It was identified that there is a need for future 
studies to focus more on weight control as an important modulator of CVD risk.  
 
Results from all these trials will substantively add to the evidence base in their 
specific areas.  
 
Recommendations 
 
• Encouragement of all future intervention trials to be statistically well powered.  
• All future trials should consider the inclusion of run in phase. 
 Research recommendation 
 
• Investigations into foods with intact grain for example muesli, oats versus 
processed wholegrain foods like bread.  
• Further investigation into the different types of fruit and vegetables and CVD 
risk. 
• Further studies to focus on weight control and the risk of CVD. 
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